EFIKA SCIENCES
0691.575.356 · rovalta.com · 09/11/2026
EFIKA SCIENCES
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOEFIKA SCIENCES is a Private company with limited liability incorporated in 2018. Its main activity is: Management consultancy activities. Its registered office is in Zwalm.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0691.575.356
- Incorporation
- 28/02/2018
- Legal form
- Private company with limited liability
- Registered office
- Veldstraat(Munk) 12
9630 Zwalm · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 18 k € | -71.9% | 64 k € | -30.6% | 92,3 k € | -33.7% | 139,3 k € | +41.7% | 98,3 k € |
| EBITDA | 17,4 k € | -72.5% | 63,5 k € | -30.8% | 91,8 k € | -33.9% | 138,9 k € | +41.9% | 97,9 k € |
| Operating result | -15,7 k € | -129% | 54,2 k € | -38.8% | 88,5 k € | -34.8% | 135,7 k € | +53.2% | 88,6 k € |
| Net result | -17,1 k € | -141% | 41,6 k € | -32.8% | 61,9 k € | -40.2% | 103,5 k € | +50.9% | 68,6 k € |
| Balance sheet | |||||||||
| Equity | 106,7 k € | -53.3% | 228,3 k € | +22.3% | 186,7 k € | +49.6% | 124,8 k € | -24.0% | 164,3 k € |
| Total assets | 326,1 k € | -18.8% | 401,9 k € | +31.3% | 306,1 k € | -10.5% | 342,1 k € | +41.3% | 242,1 k € |
| Cash | 155,9 k € | -27.1% | 214 k € | +3.4% | 207 k € | -26.4% | 281,1 k € | +51.1% | 186 k € |
| Debts | 212,3 k € | +26.6% | 167,6 k € | +46.2% | 114,7 k € | -46.4% | 213,7 k € | +183% | 75,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
VEERLE DE COLVENAER | Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
DAVY VAN GAVER | Director28/02/2018 → 2019 accountsManager28/02/2018 → 2018 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2026 | 30/09/2025 | 28/08/2024 | 30/08/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 01/06/2026 | 22/09/2025 | 03/06/2024 | 05/06/2023 | 06/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 30/09/2026 | Dutch | |
| Micro model | 31/12/2024 | 22/09/2025 | 30/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 03/06/2024 | 28/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 05/06/2023 | 30/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 06/06/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/06/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 03/09/2020 | 30/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 03/06/2019 | 31/08/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
VEERLE DE COLVENAER | Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
DAVY VAN GAVER | Director28/02/2018 → 2019 accountsManager28/02/2018 → 2018 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Veldstraat(Munk) 12, 9630 ZwalmCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00535231 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| EFIKA SCIENCESCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00535231 |
Events
- 2025Annual accounts 2025-17,1 k €↓
- 2024Annual accounts 202441,6 k €↓
- 2023Annual accounts 202361,9 k €↓
- 2022Annual accounts 2022103,5 k €↑
- 2021Annual accounts 202168,6 k €↑
- 2020Annual accounts 202052,3 k €↑
- 2019Annual accounts 2019-10 k €↓
- 2018Annual accounts 201834,8 k €
- 28/02/2018IncorporationPrivate company with limited liability